Enteroendocrine Neurons In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Enteroendocrine Neurons are specialized sensory cells in the gastrointestinal tract that detect nutrients and chemical signals, connecting the gut to the brain through neural and hormonal pathways. These cells are increasingly recognized for their role in gut-brain axis communication and their involvement in neurodegenerative disease pathogenesis.
Enteroendocrine cells (EECs) constitute the largest endocrine organ in the body and include multiple cell types that:
- Sense luminal contents
- Release signaling molecules
- Communicate with enteric nervous system
- Modulate brain function via neural and hormonal pathways
| Cell Type |
Primary Signal |
Location |
Function |
| I cells |
CCK |
Duodenum |
Fat/protein sensing |
| K cells |
GIP |
Duodenum/jejunum |
Glucose sensing |
| L cells |
GLP-1, PYY |
Ileum/colon |
Nutrient sensing |
| S cells |
Secretin |
Duodenum |
Acid sensing |
| N cells |
Neurotensin |
Jejunum |
Fat sensing |
| Enterochromaffin |
Serotonin |
Throughout |
Chemical sensing |
flowchart TD
A[Enteroendocrine Cell] --> B[Vagus Nerve] -->
B --> C[Nucleus Tractus Solitarius)
C --> D[Thalamus)
D --> E[Insula/Cortex] -->
A --> F[Hormonal Signaling] -->
F --> G[Circulation] -->
G --> H[Hypothalamus)
H --> I[Behavioral Effects] -->
J[Gut Microbiome] --> A
A --> K[Enteric Nervous System]
- Serotonin (5-HT): Enterochromaffin cells produce 95% of body serotonin
- GLP-1: Glucagon-like peptide-1, affects appetite and cognition
- PYY: Peptide YY, satiety signaling
- CCK: Cholecystokinin, gut-brain peptide
- GABA: Inhibitory neurotransmitter
- Dopamine: Reward and movement
- Alpha-synuclein in enteric nervous system
- Lewy bodies in gut neurons early in disease
- Constipation as prodromal symptom
- Vagus nerve as propagation route
- Gut microbiome alterations
- Inflammatory markers linked to AD
- Serotonin production changes
- Nutrient sensing dysregulation
- GI dysfunction in ALS patients
- Gut microbiome changes
- Metabolic alterations
- Inflammation propagation
- Bacterial translocation
- Systemic inflammation
- Cytokine entry into brain
- Microglial activation
- Gut as initiation site for α-syn
- Prion-like propagation along vagus
- Tissue cross-contamination
- Nutrient sensing impairment
- Hormonal signaling disruption
- Energy homeostasis changes
| Approach |
Target |
Status |
| Probiotics |
Microbiome |
Clinical trials |
| Fecal transplant |
Microbiome |
Investigational |
| GLP-1 agonists |
Hormonal signaling |
Approved for diabetes, research for PD |
| 5-HT modulation |
Serotonin pathway |
Research |
- Serum serotonin metabolites
- Gut hormone levels
- Microbiome analysis
- Inflammatory markers
- Organoid-gut-brain models
- Tracing studies
- Germ-free animal models
- Gnotobiotics
- Endoscopy with biopsy
- Microbiome sequencing
- Metabolomics
- Functional imaging
The study of Enteroendocrine Neurons In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak H, et al. (2003). Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease. Neurobiol Aging. 24(2):197-211.
- Sampson TR, et al. (2016). Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 167(6):1469-1480.
- Cryan JF, et al. (2019). The gut-brain axis. Physiol Rev. 99(4):1877-2013.
- Vanhoecke V, et al. (2015). Enteroendocrine cells: a link between the gut and neurodegeneration. J Neurodegener. 2:1.
- Bohn B, et al. (2018). GLP-1 and neurodegeneration. Curr Opin Neurol. 31(4):453-460.